High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial
Author(s):
Willemze, R. (0000-0001-9115-3106); Suciu, S.; Meloni, G.; Labar, B.; Marie, J.P.; Halkes, C.J.M.; Muus, P.; Mistrik, M.; Amadori, S.; Specchia, G.; Fabbiano, F.; Nobile, F.; Sborgia, M.; Camera, A.; Selleslag, D.L.D.; Lefrere, F.; Magro, D.; Sica, S.; Cantore, N.; Beksac, M.; Berneman, Z.; Thomas, X.; Melillo, L.; Guimaraes, J.E.; Leoni, P.; Luppi, M.; Mitra, M.E.; Bron, D.; Fillet, G.; Marijt, E.W.A.; Venditti, A.; Hagemeijer, A.; Mancini, M.; Jansen, J.; Cilloni, D.; Meert, L.; Fazi, P.; Vignetti, M.; Trisolini, S.M.; Mandelli, F.; Witte, T. de
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-01-20
Language
English
Is part of
Journal of Clinical Oncology (2014), Vol. 32, no. 3, p. 219-+
